Russell Investments Group, Ltd. Curis Inc Transaction History

Russell Investments Group, Ltd.

  • $60.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022
SELL
$0.74 - $15.01 $122,282 - $2.48 Million
-165,246 Reduced 31.98%
351,466 $246,000
Q2 2022

Jul 29, 2022
BUY
$0.71 - $2.43 $247,529 - $847,178
348,633 Added 207.42%
516,712 $507,000
Q1 2022

May 05, 2022
BUY
$2.31 - $5.13 $381,718 - $847,711
165,246 Added 5832.9%
168,079 $398,000
Q3 2021

Nov 08, 2021
BUY
$6.94 - $8.85 $19,661 - $25,072
2,833 New
2,833 $22,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email